These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6746709)
41. Review of experimental studies on nitrosourea derivatives in Japan. Tsukagoshi S Recent Results Cancer Res; 1980; 70():107-17. PubMed ID: 7355242 [TBL] [Abstract][Full Text] [Related]
42. Examination of newly synthesized 2-chloroethyl-nitrosoureas on rat leukemia L 5222. Zeller WJ; Eisenbrand G Oncology; 1981; 38(1):39-42. PubMed ID: 7443175 [TBL] [Abstract][Full Text] [Related]
43. Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose. Fujimoto S; Wang Y; Ogawa M Cancer Chemother Pharmacol; 1984; 12(3):173-8. PubMed ID: 6584235 [TBL] [Abstract][Full Text] [Related]
44. Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia. Hansch C; Leo A; Schmidt C; Jow PY; Montgomery JA J Med Chem; 1980 Oct; 23(10):1095-101. PubMed ID: 7420354 [TBL] [Abstract][Full Text] [Related]
45. Carcinostatic effect of 1,1'-polymethylenebis-(1-nitrosourea) on AH-13 and L-1210 cells. Nakadate M; Anzai M; Suzuki I; Ishidate M; Odashima S Gan; 1973 Aug; 64(4):415-6. PubMed ID: 4356566 [No Abstract] [Full Text] [Related]
46. [Comparative studies on anti-tumor effects of nitrosoureas, ACNU and MCNU, on experimental brain tumors (author's transl)]. Harada K; Kiya K; Okamoto H; Uozumi T Neurol Med Chir (Tokyo); 1981 Oct; 21(10):1017-23. PubMed ID: 6172720 [No Abstract] [Full Text] [Related]
47. [Effect of a bifunctional derivative of nitrosoalkylurea on the growth of experimetal tumors]. Vasil'eva LS; Gumanov LL; D'iachkovskaia RF; Konovalova NP; Surkova NI Izv Akad Nauk SSSR Biol; 1973; 5():737-9. PubMed ID: 4796871 [No Abstract] [Full Text] [Related]
48. Anticancer activity of new nitrosoureas against Walder carcinosarcoma 256 and DMBA-induced mammary cancer of the rat. Fiebig HH; Eisenbrand G; Zeller WJ; Zentgraf R Oncology; 1980; 37(3):177-83. PubMed ID: 6444708 [TBL] [Abstract][Full Text] [Related]
49. New type bifunctional nitrosoureido derivatives with cytostatic activity. Csányi E; Horváth T; Király E; Lapis K; Kopper L Oncology; 1980; 37 Suppl 1():59-66. PubMed ID: 7454201 [TBL] [Abstract][Full Text] [Related]
50. A new class of nitrosoureas. VI. Synthesis and antitumor activity of 3-substituted-1-(2-chloroethyl)-3-(methyl-alpha-D-glucopyranosid-2-yl)-1-nitrosoureas. Morikawa T; Takeda M; Arai Y; Tsujihara K Chem Pharm Bull (Tokyo); 1982 Jul; 30(7):2386-92. PubMed ID: 7139813 [No Abstract] [Full Text] [Related]
51. A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs. Geran RI; Congleton GF; Dudeck LE; Abbott BJ; Gargus JL Cancer Chemother Rep 2; 1974 Dec; 4(4):53-87. PubMed ID: 4447935 [No Abstract] [Full Text] [Related]
52. CGP 6809, a sugar-containing nitrosourea derivative: pharmacological and physicochemical properties. Schieweck K; Stanek J; Kanter PM; Schmidt-Ruppin KH; Müller M; Matter A Cancer Chemother Pharmacol; 1989; 23(6):341-7. PubMed ID: 2713956 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma. Montgomery JA; McCaleb GS; Johnston TP; Mayo JG; Laster WR J Med Chem; 1977 Feb; 20(2):291-5. PubMed ID: 836501 [TBL] [Abstract][Full Text] [Related]
54. Chronic toxicity and carcinogenicity of cytostatic N-nitroso-(2-chloroethyl) ureas after repeated intravenous application to rats. Eisenbrand G; Habs M Dev Toxicol Environ Sci; 1980; 8():273-8. PubMed ID: 7308028 [No Abstract] [Full Text] [Related]
55. In the search for new anticancer drugs. 27. Synthesis and comparison of anticancer activity in vivo of amino acids, carbohydrates, and carbohydrate-amino acid conjugates containing the [N'-(2-chloroethyl)-N'-nitrosoamino]carbonyl group. Sosnovsky G; Gnewuch CT J Pharm Sci; 1994 Jul; 83(7):989-98. PubMed ID: 7965679 [TBL] [Abstract][Full Text] [Related]
56. Effect of the pretreatment with disulfiram on the toxicity and antitumor activity of 1-(2-hydroxyethyl)-3-(2-chloroethyl)-3-nitrosourea in Sprague--Dawley rats. Habs H; Habs M Cancer Lett; 1981 Jun; 13(1):63-9. PubMed ID: 7306945 [TBL] [Abstract][Full Text] [Related]
57. Clinical comparison of the nitrosoureas. Wasserman TH; Slavik M; Carter SK Cancer; 1975 Oct; 36(4):1258-68. PubMed ID: 1100221 [TBL] [Abstract][Full Text] [Related]
58. The pharmacokinetic model and distribution pattern of new sexual-steroid-hormone-linked anticancer agents. Betsch B J Cancer Res Clin Oncol; 1990; 116(5):467-9. PubMed ID: 2229135 [TBL] [Abstract][Full Text] [Related]
59. Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates. Baril BB; Baril EF; Laszlo J; Wheeler GP Cancer Res; 1975 Jan; 35(1):1-5. PubMed ID: 162855 [TBL] [Abstract][Full Text] [Related]
60. Biologic activity of MCNU: a new antitumor agent. Sekido S; Ninomiya K; Iwasaki M Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]